Company profile

Fate Therapeutics Inc Insider Trading

FATE

Every SEC Form 4 insider trading filing for Fate Therapeutics Inc (FATE) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
CIK
0001434316
Filings
90
Insiders
23
Last filing
2026-08-04

Activity summary

Recent insider activity is bearish. Over the last 30 days, insiders net sold $204K across 2 transactions.

Three year balance

Buy and sell value by quarter, Q4 23 to Q3 26. Fate Therapeutics Inc insiders are net buyers across the period shown.

Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $20.0M.

90 day insight

Over the last 90 days, Fate Therapeutics Inc insiders bought $0 (9 transactions) and sold $204K (2 transactions).

  • Most active insider: Valamehr Bahram with 1 transaction totaling $108K.
  • Largest single sale: $108K by Valamehr Bahram on Aug 4, 2026.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 4, 2026Tahl CindyFATE
Sale
38,800$2.46$95K
Aug 4, 2026Valamehr BahramFATE
Sale
43,947$2.46$108K
Jun 12, 2026Hamill LauraFATE
Award
175,800
Jun 12, 2026Xu YuanFATE
Award
87,900
Jun 12, 2026Redmile Group, LLCFATE
Award
87,900

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=FATE" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Tahl CindySee Remarks6 filings+$44K
Valamehr BahramPresident and CEO4 filings$184K
Rastetter William HDirector1 filing+$42K
Epstein Robert SDirector1 filing+$42K

Institutional Ownership

Top 13F-HR holders of Fate Therapeutics Inc as of 2026-06-30

↓ decreasing
Total reported AUM
$34.4M
QoQ change
-55.6%
Reporting period
2026-06-30
#1
BlackRock, Inc.
CIK 0002012383
$9.3M
3.4M shares
#2
Johnson & Johnson
CIK 0000200406
$9.1M
3.4M shares
#3
BlackRock, Inc.
CIK 0002012383
$5.0M
1.8M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →